Hermès Menswear Marks Historic Transition as Véronique Nichanian Bids Farewell in Paris 
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand 
Toyota Recalls 162,000 Tundra Vehicles in U.S. Over Multimedia Display Issue 
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut 
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns 
CN Energy Group Inc. Stock Slides After Nasdaq Delisting Notice Over Bid Price Rule 
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates 
Winter Storm Triggers Widespread Flight Cancellations Across U.S. as Airlines Urge Travelers to Rebook 
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices 
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market 
Nintendo Stock Jumps as Switch 2 Becomes Best-Selling Console in the U.S. in 2025 
Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas 
JERSEY, Channel Islands, May 09, 2017 -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and fiscal year ended March 31, 2017 will be released after market close on Monday, May 22, 2017.
Quotient will host a conference call on Tuesday, May 23 at 8:00 a.m. Eastern Time to discuss its fourth quarter and fiscal year 2017 financial results. Participants may access the call by dialing 1-877-407-0784 in the U.S. or 1-201-689-8560 outside the U.S. The conference call will be webcast live on the Company's website at www.quotientbd.com.
A replay of this conference call will be available through May 30 by dialing 1-844-512-2921 in the U.S. or 1-412-317-6671 outside the U.S. The replay access code is 13660555.
About Quotient Limited
Quotient is a commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovative tests within established markets. With an initial focus on blood grouping and serological disease screening, Quotient is developing its proprietary MosaiQ™ technology platform to offer a breadth of tests that is unmatched by existing commercially available transfusion diagnostic instrument platforms. The company's operations are based in Edinburgh, Scotland; Eysins, Switzerland and Newtown, Pennsylvania.
The Quotient logo and MosaiQ™ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.
CONTACT: Christopher Lindop, Chief Financial Officer — [email protected]; +41 22-545-5226
